NATIONAL INSTITUTES OF HEALTH DIRECTOR'S PIONEER AWARD [NDPA]
RELEASE DATE: January 23, 2004
NOTICE: NOT-RM-04-007
National Institutes of Health (NIH)
NIH Director's Pioneer Award Program
http://nihroadmap.nih.gov/highrisk/initiatives/pioneer/index.asp
NOMINATIONS MUST BE SUBMITTED BY MIDNIGHT, APRIL 1, 2004.
SUMMARY
NIH, in acknowledgment of the changing face of biomedical research, is
announcing a new program, The NIH Director’s Pioneer Award. While the
term biomedical research is used throughout this notice it should be
broadly interpreted to include the scientific investigations of
biomedical, behavioral, social, physical, chemical and computer
scientists; engineers; and mathematicians.
History suggests that leaps in knowledge frequently result from
exceptional minds willing and able to explore ideas that were
considered risky at their inception, especially in the absence of
strong supportive data. Such individuals are more likely to take such
risks when they are assured of adequate funds for a sufficient period
of time, and with the freedom to set their own research agenda. The
NIH Director’s Pioneer Award (NDPA) program is being established to
identify and fund investigators of exceptionally creative abilities and
diligence, for a sufficient term (five years) to allow them to develop
and test far-ranging ideas. Awardees are expected to commit the major
portion of their effort to activities supported by the NDPA. The
program is not intended to support ongoing research projects or simply
expand the funding of persons already well supported.
The only constraint on the research to be done with this Award will be
that it must be relevant to the NIH mission.
BACKGROUND
The spectacular advances made in the biological and medical sciences in
the last few decades have opened doors to even greater opportunities in
the 21st century. The National Institutes of Health has been, and will
continue to be, a major player in the support of this groundbreaking
research. Much of the NIH success derives from its reliance on
investigator-initiated research proposals (the bedrock R01 award) and
its dual system of peer review and advisory council oversight.
However, there is evidence that some additional means may be necessary
to further accelerate advances in medical science and the resulting
gains in the health and well-being of the American people.
The face of biomedical research is changing. Many of the new
opportunities for research involve crossing traditional disciplinary
lines and bringing forward different conceptual frameworks as well as
methodologies. These developments appear to justify support for more
aggressive risk-taking and innovation. While the current NIH funding
system will continue to support groundbreaking research and innovation
within the context of its traditional research grant mechanisms,
additional avenues seem necessary to encourage high risk/high impact
research in this new context.
To address this issue, NIH convened a group of highly distinguished
outside consultants with expertise in biomedical, behavioral and social
sciences, physical sciences, and engineering, representing academia,
foundations, business and industry. This group proposed that NIH
implement novel programs targeted specifically to identify, encourage,
and support the people and projects that will produce tomorrow’s
conceptual and technological breakthroughs. These programs would
complement the other NIH research grants programs and would provide
additional opportunities to those afforded within the Institutes and
Centers for research that contests the status quo across the breadth of
the NIH mission. A first step in this process is the establishment of a
new NIH program to support exceptionally creative individual
scientists.
SUMMARY OF THE AWARD PROCESS The award process is summarized briefly
below and in detail at
http://nihroadmap.nih.gov/highrisk/initiatives/pioneer/faq.asp.
ELIGIBILITY
Nominees for the NDPA must be U. S. citizens, non-citizen nationals, or
permanent residents who are currently engaged in research. The
research need not be related to conventional biomedical or behavioral
disciplines; if the individual’s experience is in non-biological areas
there must be evidence of interest in exploring topics of biomedical
relevance. If selected, individuals must show evidence of
infrastructure support. Investigators at early stages of their career
as well as those who are established will be eligible.
THE NOMINATION PROCESS
In the first phase of the application process, nominations will be
submitted by mentors, colleagues, institutions, or by the individuals
themselves. Only a single nomination package may be submitted for each
person. The nomination package will include a letter and the nominee’s
resume or Curriculum Vita, each no more than two pages in length.
The letter will explain why the nominee should be considered
exceptional and therefore highly likely to pursue original avenues of
inquiry directed at very challenging biomedical problems. Although
creativity comes in many forms, aspects common to innovative people
include an interest in, and the ability to integrate, diverse sources
of information, an inclination to challenge paradigms and take
intellectual risks, resilience in the face of failure, an ability to
attract the right collaborators, and the diligence and concentration
necessary to plan and execute effective strategies for accomplishing
goals. The letter should also provide evidence of the nominee’s
interest in the types of biomedical problems that are particularly
overdue for fresh approaches.
Nominations will be submitted via the Internet to
http://nihroadmap.nih.gov/highrisk/initiatives/pioneer/index.asp. The
website will be open to receive nominations from March 1, 2004 through
midnight April 1, 2004, Eastern Standard Time.
THE SELECTION PROCESS
All nominations will be evaluated by NIH staff for eligibility and by
outside experts to identify promising candidates who will be invited
formally to apply for the NDPA. In the second phase of this process
beginning mid June, the candidates will be asked to provide an essay of
3-5 pages describing their views on the major challenges in biomedical
and behavioral research to which they feel they can make seminal
contributions. No detailed scientific plan should be provided since
the research plan will be expected to evolve during the tenure of the
grant. In addition, each candidate will submit a copy of his/her most
significant publication or achievement and arrange for direct
submission of letters of support from three individuals who may or may
not have been nominators. A subset of the candidates will be
interviewed in August-September 2004, by a panel of outside experts.
Additional input will be provided by the Advisory Committee to the
Director and final selections will be completed and announced by the
end of September 2004.
AWARDS
To inaugurate this program sufficient funds have been set aside in 2004
to provide 5-10 awards. The awards will be up to $500,000 direct costs
each year, for five years. Although there are no stipulations on the
research agenda, the awardee will be required to submit an annual
report of activities conducted during the year and to participate in an
annual symposium on the NIH campus. This symposium will allow awardees
to share their ideas, progress, and experience with each other, the
research community, and NIH staff.
INQUIRIES
The NIH Director's Pioneer Award is among several initiatives being
undertaken as a part of the NIH Roadmap Activities. To learn more about
the award, please refer to the NIH Roadmap Web site at
http://nihroadmap.nih.gov, or E-mail your questions to [email protected].
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
| ||||||
Department of Health and Human Services (HHS) |
||||||
NIH... Turning Discovery Into Health® |